| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
8,317 |
7,088 |
$400K |
| 99215 |
Prolong outpt/office vis |
238 |
228 |
$20K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
639 |
517 |
$15K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
254 |
191 |
$10K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
275 |
205 |
$10K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
468 |
367 |
$4K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
237 |
209 |
$2K |
| 36415 |
Collection of venous blood by venipuncture |
1,050 |
964 |
$2K |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
211 |
195 |
$1K |
| 96127 |
|
522 |
361 |
$1K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
50 |
45 |
$1K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
27 |
27 |
$1K |
| 90674 |
|
52 |
48 |
$1K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
148 |
67 |
$705.77 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
19 |
15 |
$169.49 |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
119 |
55 |
$92.98 |
| 99173 |
|
37 |
13 |
$23.44 |
| 3008F |
|
432 |
391 |
$0.00 |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
83 |
74 |
$0.00 |
| 3074F |
|
254 |
233 |
$0.00 |
| 3079F |
|
45 |
44 |
$0.00 |
| 3078F |
|
163 |
147 |
$0.00 |